Synopsys
SNPS
$384.27
-7.85%
Synopsys is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP), enabling chip designers to create and verify complex integrated circuits. As a dominant player in the EDA industry, Synopsys benefits from the secular trend of digitalization and the convergence of semiconductor and systems companies, positioning it as a critical enabler of the AI and chip design ecosystem. The current investor narrative centers on the company's growth trajectory following its acquisition of Ansys, which expands its simulation capabilities, though near-term organic growth concerns and integration risks have weighed on the stock, creating a divergence between analyst optimism and market sentiment.…
SNPS
Synopsys
$384.27
Related headlines
SNPS 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Synopsys's 12-month outlook, with a consensus price target around $563.99 and implied upside of +46.8% versus the current price.
Average Target
$563.99
0 analysts
Implied Upside
+46.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$404 - $650
Analyst target range
Synopsys is covered by 25 analysts, with a consensus recommendation of 'Buy' (mean rating 1.71 on a 1-5 scale). The average price target is $563.99, implying 32.6% upside from the current price of $425.28. The distribution shows a bullish tilt, with firms like Rosenblatt, Needham, and Stifel reiterating Buy ratings, while Piper Sandler recently upgraded from Neutral to Overweight. However, BNP Paribas maintains an Underperform rating, indicating some bearish divergence. The target range spans from a low of $403.85 to a high of $650.00, representing a wide spread of $246.15, which signals high uncertainty about the stock's future. The high target of $650 assumes successful integration of Ansys, margin expansion, and accelerated growth from AI-driven chip design demand, while the low target of $403.85 prices in integration challenges, competitive pressure, or a macro slowdown. Recent ratings actions show mostly reaffirmations, with no major downgrades, suggesting analysts remain confident despite the stock's decline. The wide target range and mixed ratings imply that while the consensus is bullish, conviction is not uniform, and investors should weigh the potential upside against the risks highlighted by the low-end estimates.
Bulls vs Bears: SNPS Investment Factors
Synopsys presents a classic value trap versus turnaround debate. On the bull side, the company dominates the EDA market, has strong analyst support with 32.6% upside, and maintains healthy gross margins and cash flow. On the bear side, earnings have collapsed due to acquisition costs, the stock is in a sustained downtrend, and the trailing P/E is expensive relative to peers. The single most important tension is whether the Ansys acquisition will deliver the expected synergies and margin expansion, or if integration challenges and debt costs will continue to depress profitability. Currently, the bear case has stronger evidence given the earnings deterioration and technical weakness, but the bull case hinges on a successful turnaround.
Bullish
- Dominant EDA Market Position: Synopsys is the leading provider of EDA software and semiconductor IP, benefiting from secular trends in digitalization and AI-driven chip design. The company's comprehensive portfolio positions it as a critical enabler for both semiconductor and systems companies, expanding its total addressable market.
- Strong Revenue Growth from Ansys: Revenue surged 41.9% year-over-year to $2.276 billion in Q2 2026, driven by the Ansys acquisition. This growth accelerates from the prior quarter's 10.9% rate, demonstrating the strategic value of the acquisition in expanding simulation capabilities.
- Analyst Consensus Buy with 32.6% Upside: The average analyst price target is $563.99, implying 32.6% upside from the current price of $425.28. With 25 analysts covering, the consensus recommendation is Buy (mean rating 1.71), indicating broad professional optimism.
- Healthy Gross Margin and Cash Flow: Gross margin remains robust at 72.3%, and the company generated $617 million in free cash flow in Q2 2026. Trailing twelve-month free cash flow of $2.676 billion provides ample liquidity for debt servicing and investment.
Bearish
- Earnings Collapse from Acquisition Costs: Net income plummeted to $17.1 million in Q2 2026 from $448.7 million in Q4 2025, a 96% decline. Net margin fell to just 0.75%, reflecting high interest expenses and integration costs from the Ansys acquisition.
- Stock in Sustained Downtrend: The stock has declined 25.3% over the past year and is trading 35% below its 52-week high of $651.73. With a beta of 1.222, the stock is more volatile than the market, amplifying downside risk.
- Elevated Trailing P/E Relative to Peers: The trailing P/E of 55.8x is 86% above the software-infrastructure industry average of ~30x. While the forward P/E of 24.6x is lower, the current multiple still implies high expectations for a sharp earnings recovery.
- Organic Growth Concerns Masked by Acquisition: The 41.9% revenue growth is largely due to the Ansys acquisition. Excluding this, organic growth may be weaker, as suggested by the sequential revenue decline from $2.409 billion in Q1 2026 to $2.276 billion in Q2 2026.
SNPS Technical Analysis
Synopsys is in a sustained downtrend, with the stock declining 25.3% over the past year and currently trading at $425.28, just 13% above its 52-week low of $376.18 and 35% below the 52-week high of $651.73. This positioning near the low end of the range suggests bearish momentum and potential value trap risks, as the stock has failed to recover from its multi-month slide. Over the past three months, the stock has fallen 3.6%, while the one-month change shows a sharper decline of 6.4%, indicating accelerating selling pressure. The short-term momentum is diverging from the longer-term downtrend, as the 1-month relative strength versus SPY is -7.0%, significantly underperforming the market. This divergence could signal a potential mean-reversion bounce, but the persistent weakness suggests further downside risk. The 52-week low at $376.18 provides key support, while resistance lies at the 52-week high of $651.73. A breakdown below $376 could trigger further selling, while a move above $500 would indicate a reversal. With a beta of 1.222, Synopsys is 22% more volatile than the S&P 500, amplifying both upside and downside moves, which is critical for risk management.
Beta
1.22
1.22x market volatility
Max Drawdown
-41.0%
Largest decline past year
52-Week Range
$366-$652
Price range past year
Annual Return
-34.8%
Cumulative gain past year
| Period | SNPS Return | S&P 500 |
|---|---|---|
| 1m | -16.8% | +0.3% |
| 3m | -14.5% | +4.7% |
| 6m | -25.6% | +7.5% |
| 1y | -34.8% | +18.4% |
| ytd | -20.0% | +9.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SNPS Fundamental Analysis
Revenue grew 41.9% year-over-year to $2.276 billion in the most recent quarter (Q2 2026), accelerating from the prior quarter's 10.9% growth, driven by strong license and maintenance revenue of $945.6 million and technology services of $784.1 million. However, the sequential revenue decline from Q1 2026's $2.409 billion suggests lumpiness in license revenue, and the organic growth excluding the Ansys acquisition may be weaker. The company's net income was just $17.1 million in Q2 2026, a sharp drop from $448.7 million in Q4 2025, due to higher interest expenses and operating costs, resulting in a net margin of only 0.75%. Gross margin remained healthy at 72.3%, but operating margin compressed to 10.4% from 23.5% a year earlier, reflecting integration costs and increased R&D spending. The company has a debt-to-equity ratio of 0.50 and generated $671 million in operating cash flow and $617 million in free cash flow in Q2 2026, providing ample liquidity. However, the trailing twelve-month free cash flow of $2.676 billion implies a FCF yield of 3.7%, which is modest relative to the market cap. The current ratio of 1.62 indicates adequate short-term liquidity, but the elevated debt levels from the Ansys acquisition warrant monitoring.
Quarterly Revenue
$2.3B
2026-04
Revenue YoY Growth
+41.9%
YoY Comparison
Gross Margin
72.3%
Latest Quarter
Free Cash Flow
$2.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SNPS Overvalued?
Since net income is positive, we lead with the P/E ratio. The trailing P/E is 55.8x, while the forward P/E is 24.6x, implying the market expects significant earnings growth in the coming year. The large gap between trailing and forward P/E suggests that the market is pricing in a sharp recovery in profitability, which is consistent with the recent earnings dip due to acquisition-related costs. Compared to the software-infrastructure industry average P/E of approximately 30x, Synopsys trades at a 86% premium on a trailing basis, but on a forward basis, the 24.6x multiple is at a discount to the industry average, indicating that the market expects normalized earnings to justify a lower multiple. Historically, Synopsys' trailing P/E has ranged from 37x to 1340x over the past two years, with the current 55.8x near the lower end of that range, suggesting the stock is relatively cheap by its own historical standards. However, the elevated trailing multiple reflects the temporary earnings compression, and the forward P/E near historical lows implies that the market is pricing in a recovery but remains cautious.
PE
55.8x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 37x~73x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
33.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is the sharp decline in net income, which fell to $17.1 million in Q2 2026 from $448.7 million in Q4 2025, a 96% drop. This is driven by high interest expenses of $133 million and increased operating costs from the Ansys acquisition. The net margin of 0.75% is unsustainable, and if the company fails to restore profitability, the stock could face further downside. Additionally, the debt-to-equity ratio of 0.50, while manageable, adds leverage risk in a rising interest rate environment. The company's reliance on license revenue, which can be lumpy, is evident from the sequential revenue decline of 5.5% from Q1 to Q2 2026.
Market & Competitive Risks: Synopsys trades at a trailing P/E of 55.8x, a 86% premium to the industry average of 30x, making it vulnerable to multiple compression if growth disappoints. The stock's beta of 1.222 indicates higher sensitivity to market downturns, and its 25.3% decline over the past year underperforms the S&P 500 by 46.2%. Competitive threats from Cadence and other EDA vendors could pressure market share, especially if customers delay chip design projects due to macro uncertainty. Recent news about GlobalFoundries acquiring Synopsys' processor IP business highlights the risk of asset sales that could reduce future revenue streams.
Worst-Case Scenario: If Synopsys fails to integrate Ansys effectively, leading to continued margin compression and organic growth stagnation, the stock could fall to its 52-week low of $376.18, representing a 11.5% decline from the current price of $425.28. In a severe recession or competitive disruption, the stock could test the analyst low target of $403.85, a 5% decline. However, the historical max drawdown of -41.04% suggests a worst-case loss of up to 41% from the 52-week high, implying a potential drop to around $384 from current levels. This scenario would require a combination of integration failure, macro downturn, and loss of key customers.